Literature DB >> 7383283

Activity of two new potent dopaminergic agonists at the striatal and anterior pituitary levels.

C Euvrard, L Ferland, T Di Paolo, M Beaulieu, F Labrie, C Oberlander, J P Raynaud, J R Boissier.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 7383283     DOI： 10.1016/0028-3908(80)90190-2

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN： 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  17 in total

1.  The Roman strains of rats as a psychogenetic tool for pharmacological investigation of working memory: example with RU 41656.

Authors:  F Willig; D Van de Velde; J Laurent; M M'Harzi; J Delacour
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Pharmacological and molecular basis for dopamine D-2 receptor diversity.

Authors:  M Memo
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

3.  Radioreceptor binding reveals the potencies of N,N-disubstituted 2-aminotetralins as D2 dopamine agonists.

Authors:  P M Beart; C J Cook; M Cincotta; D J de Vries; P Tepper; D Dijkstra; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

4.  Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213.

Authors:  A M Deveney; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

5.  Neurochemical and behavioural profiles of five dopamine analogues.

Authors:  C Sumners; D Dijkstra; J B de Vries; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-07       Impact factor: 3.000

6.  Bimodal effects of dopamine D2 receptor agonists on zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice.

Authors:  A M Alam; M S Starr
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

7.  Biochemical, behavioural, and endocrine effects of CK 204-933, a novel 8 beta-ergolene.

Authors:  R Markstein; A Enz; J M Vigouret; A Jaton; A Closse; U Briner; P Gull
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

8.  Dopamine autoreceptors and the effects of drugs on locomotion and dopamine synthesis.

Authors:  F Brown; W Campbell; P J Mitchell; K Randall
Journal:  Br J Pharmacol       Date:  1985-04       Impact factor: 8.739

9.  Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice.

Authors:  M S Starr; B S Starr
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

10.  The effects of clozapine on behavioural responses to the selective 'D1-like' dopamine receptor agonist, A 68930, and to the selective 'D2-like' agonist, RU 24213.

Authors:  S A Daly; J L Waddington
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.